Log in

NASDAQ:BRKRBruker Stock Price, Forecast & News

-0.86 (-1.95 %)
(As of 08/14/2020 04:00 PM ET)
Today's Range
Now: $43.13
50-Day Range
MA: $42.00
52-Week Range
Now: $43.13
Volume160,626 shs
Average Volume766,802 shs
Market Capitalization$6.60 billion
P/E Ratio40.69
Dividend Yield0.36%
Bruker Corporation manufactures and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates in two segments, Bruker Scientific Instruments, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry solutions; infrared spectroscopy and radiological/nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection in emergency response, homeland security, and defense applications; and research, analytical, and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies. The company also provides X-ray instruments, atomic force microscopy instrumentation, fluorescence optical microscopy instruments, analytical tools for electron microscopes and X-ray metrology, defect-detection equipment for semiconductor process control, and spark optical emission spectroscopy systems, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments. In addition, it offers superconducting and non-superconducting materials and devices. The company serves pharmaceutical, biotechnology, and diagnostics companies; chemical, food and beverage, clinical, and polymer companies; nonprofit laboratories; contract research organizations, academic institutions, medical schools, nonprofit or for-profit forensics, environmental and clinical microbiology laboratories, and hospitals and government departments and agencies, as well as agriculture, and food and beverage safety companies; nanotechnology, semiconductor, and industrial companies; and raw material manufacturers and other businesses through direct sales forces, distributors, independent sales representatives, and other representatives. Bruker Corporation was incorporated in 1991 and is headquartered in Billerica, Massachusetts.
Read More
Bruker logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.2Community Rank: 2.4Dividend Strength: 1.7Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.49 out of 5 stars

Industry, Sector and Symbol

Industry Analytical instruments
Sub-IndustryLife Sciences Tools & Services
Current SymbolNASDAQ:BRKR



Sales & Book Value

Annual Sales$2.07 billion
Cash Flow$2.03 per share
Book Value$5.88 per share


Net Income$197.20 million


Market Cap$6.60 billion
Next Earnings Date10/29/2020 (Estimated)
-0.86 (-1.95 %)
(As of 08/14/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive BRKR News and Ratings via Email

Sign-up to receive the latest news and ratings for BRKR and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Bruker (NASDAQ:BRKR) Frequently Asked Questions

How has Bruker's stock price been impacted by COVID-19?

Bruker's stock was trading at $40.00 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, BRKR shares have increased by 7.8% and is now trading at $43.13.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of Bruker?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bruker in the last year. There are currently 1 sell rating, 5 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Bruker

When is Bruker's next earnings date?

Bruker is scheduled to release its next quarterly earnings announcement on Thursday, October 29th 2020.
View our earnings forecast for Bruker

How were Bruker's earnings last quarter?

Bruker Co. (NASDAQ:BRKR) released its quarterly earnings data on Monday, August, 3rd. The medical research company reported $0.21 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.05 by $0.16. The medical research company had revenue of $424.60 million for the quarter, compared to analyst estimates of $395.51 million. Bruker had a net margin of 8.35% and a return on equity of 22.70%. The firm's quarterly revenue was down 13.4% on a year-over-year basis. During the same period in the prior year, the business earned $0.33 earnings per share.
View Bruker's earnings history

How often does Bruker pay dividends? What is the dividend yield for Bruker?

Bruker declared a quarterly dividend on Friday, August 7th. Stockholders of record on Tuesday, September 1st will be given a dividend of $0.04 per share on Friday, September 18th. This represents a $0.16 dividend on an annualized basis and a yield of 0.37%. The ex-dividend date of this dividend is Monday, August 31st.
View Bruker's dividend history

What guidance has Bruker issued on next quarter's earnings?

Bruker updated its second quarter 2020 Pre-Market earnings guidance on Wednesday, July, 22nd. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $420-425 million, compared to the consensus revenue estimate of $388.84 million.

What price target have analysts set for BRKR?

10 brokerages have issued 12-month price targets for Bruker's shares. Their forecasts range from $27.00 to $63.00. On average, they anticipate Bruker's share price to reach $44.95 in the next twelve months. This suggests a possible upside of 4.2% from the stock's current price.
View analysts' price targets for Bruker

Has Bruker been receiving favorable news coverage?

News articles about BRKR stock have trended somewhat positive recently, according to InfoTrie Sentiment Analysis. InfoTrie scores the sentiment of media coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Bruker earned a daily sentiment score of 0.6 on InfoTrie's scale. They also assigned media stories about the medical research company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the next few days.
View the latest news about Bruker

Are investors shorting Bruker?

Bruker saw a increase in short interest in February. As of February 15th, there was short interest totaling 2,910,000 shares, an increase of 18.8% from the January 31st total of 2,450,000 shares. Based on an average daily volume of 557,900 shares, the days-to-cover ratio is currently 5.2 days. Currently, 2.8% of the shares of the stock are sold short.
View Bruker's Short Interest

Who are some of Bruker's key competitors?

What other stocks do shareholders of Bruker own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bruker investors own include AbbVie (ABBV), CVS Health (CVS), Micron Technology (MU), Alibaba Group (BABA), Cisco Systems (CSCO), Intel (INTC), Walt Disney (DIS), Applied Materials (AMAT), Bank of America (BAC) and Bristol-Myers Squibb (BMY).

Who are Bruker's key executives?

Bruker's management team includes the following people:
  • Dr. Frank H. Laukien, Chairman, CEO & Pres (Age 59)
  • Mr. Gerald N. Herman, CFO, VP & Corp. Controller (Age 61)
  • Dr. Mark R. Munch, Exec. VP and Pres of Bruker Nano Group & Bruker Nano Surfaces Division (Age 57)
  • Mr. Juergen Srega, Pres of Bruker CALID Group & Bruker Daltonics Division (Age 64)
  • Dr. Falko Busse, Exec. Officer (Age 52)

What is Bruker's stock symbol?

Bruker trades on the NASDAQ under the ticker symbol "BRKR."

Who are Bruker's major shareholders?

Bruker's stock is owned by a number of retail and institutional investors. Top institutional shareholders include FMR LLC (14.84%), Vanguard Group Inc. (7.13%), Bank of America Corp DE (0.85%), TD Asset Management Inc. (0.72%), GWM Advisors LLC (0.45%) and Palisade Capital Management LLC NJ (0.39%). Company insiders that own Bruker stock include Burkhard Prause, Cynthia M Friend, Frank H Laukien, Marc A Kastner and Mark Munch.
View institutional ownership trends for Bruker

Which major investors are selling Bruker stock?

BRKR stock was sold by a variety of institutional investors in the last quarter, including GWM Advisors LLC, First Trust Advisors LP, Vanguard Group Inc., Goldman Sachs Group Inc., FMR LLC, NN Investment Partners Holdings N.V., Mackay Shields LLC, and Russell Investments Group Ltd.. Company insiders that have sold Bruker company stock in the last year include Burkhard Prause, Cynthia M Friend, Marc A Kastner, and Mark Munch.
View insider buying and selling activity for Bruker

Which major investors are buying Bruker stock?

BRKR stock was purchased by a variety of institutional investors in the last quarter, including FIL Ltd, Alyeska Investment Group L.P., Artal Group S.A., Bank of Nova Scotia, DekaBank Deutsche Girozentrale, TD Asset Management Inc., Boston Trust Walden Corp, and Ceredex Value Advisors LLC.
View insider buying and selling activity for Bruker

How do I buy shares of Bruker?

Shares of BRKR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Bruker's stock price today?

One share of BRKR stock can currently be purchased for approximately $43.13.

How big of a company is Bruker?

Bruker has a market capitalization of $6.60 billion and generates $2.07 billion in revenue each year. The medical research company earns $197.20 million in net income (profit) each year or $1.57 on an earnings per share basis. Bruker employs 7,230 workers across the globe.

What is Bruker's official website?

The official website for Bruker is www.bruker.com.

How can I contact Bruker?

Bruker's mailing address is 40 Manning Road, Billerica MA, 01821. The medical research company can be reached via phone at 978-663-3660 or via email at [email protected]

This page was last updated on 8/15/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.